Global Antibiotic Resistance Partnership (GARP)

  21 October 2024

Antibiotic resistance is a significant issue in low- and middle-income countries with limited healthcare access, sanitation infrastructure, and public health education. The Global Antibiotic Resistance Partnership (GARP) has been working to develop actionable policy proposals to address these disparities. GARP has played a critical role in advancing country-led strategies and policies to address AMR in 15 countries in Africa and Asia since 2008. The organization has worked with member countries to contextualize AMR on national scales and provide policy recommendations. The GARP model consists of a technical working group of experts from various disciplines, including academia, non-governmental organizations, faith-based organizations, and the government.

Further reading: One Health Trust
Author(s): One Health Trust
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed